URE-39

URE-39- urea cream
SOLUTECH PHARMACEUTICALS LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Rx only

For external use only.

Not for ophthalmic use.

URE-39 Description

URE-39 Cream is a potent keratolytic emollient which is a gentle, yet potent, tissue softener for skin and/or nails.

Each gram of URE-39 Cream contains:

ACTIVE: 39% Urea in a cream base of:

INACTIVES: Deionized Water, Carthamus Tinctorius (Safflower) Seed Oil, Emulsifying Wax, Glycerine, Propylene Glycol, Glyceryl Stearate, PEG 100 Stearate, Cetyl Alcohol, Dimethicone, C12/15 Alkyl Benzoate, Anthemis Nobilis (Chamomile) Flower Extract, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Aloe Barbadensis Leaf, Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben, and Isobutylparaben.

CHEMISTRY

Urea is a diamide of carbonic acid with the following chemical structure:

Chemical StructureChemical Structure

URE-39 — Clinical Pharmacology

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas. Urea also hydrates and gently dissolves the intercellular matrix of the nail plate, which can result in the softening and eventual debridement of the nail plate.

PHARMACOKINETICS

The mechanism of action of topically applied Urea is not yet known.

INDICATIONS AND USES

For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or prurient debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

Contraindications

URE-39 Cream is contraindicated in patients with known hypersensitivity to any of the listed ingredients.

Warnings

For external use only. Avoid contact with eyes, lips or mucous membranes. Do not use on areas of broken skin.

Precautions

Stop use and ask a doctor if redness or irritation develops. After applying this medication, wash hands and unaffected areas thoroughly. If swallowed, get medical help or contact Poison Control Center right away. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.

PREGNANCY

Pregnancy Category B

Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, URE-39 Cream should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS

It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when URE-39 Cream is administered to a nursing woman.

Adverse Reactions to URE-39

Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.

URE-39 — Dosage and Administration

Apply URE-39 Cream to affected skin two to three times per day as needed or as directed by a physician. Rub in until completely absorbed. Apply to diseased or damaged nail tissue two to three times per day or as directed by a physician. Best applied to affected areas immediately after showering and just before bedtime.

How is URE-39 Supplied

URE-39 ( 39% Urea Cream) is supplied in:

8oz (227gm) Jar NDC: 70350-2612-1

Store at 25°C (77°F); excursions permitted to 15°C — 30°C (59° — 86°F). Protect from freezing. [See USP Controlled Room Temperature.]

Manufactured for:
Solutech Pharmaceuticals LLC
Peoria, AZ 85345

Rx only

PRINCIPAL DISPLAY PANEL — 227 gm Jar Label

NDC 70350-2612-1

FOR TOPICAL USE ONLY

URE-39 UREA 39% CREAM

Smooth Easily Spreadable

Rx only

Solutech
PHARMACEUTICALS

Net WT.
8OZ (227 gm)

PRINCIPAL DISPLAY PANEL -- 227 gm Jar Label
(click image for full-size original)
URE-39
urea cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70350-2612
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
UREA (UREA) UREA 390 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
WATER
SAFFLOWER OIL
GLYCERIN
PROPYLENE GLYCOL
GLYCERYL MONOSTEARATE
PEG-100 STEARATE
CETYL ALCOHOL
DIMETHICONE
ALKYL (C12-15) BENZOATE
CHAMAEMELUM NOBILE FLOWER
TEA TREE OIL
ALOE VERA LEAF
PHENOXYETHANOL
METHYLPARABEN
ETHYLPARABEN
BUTYLPARABEN
PROPYLPARABEN
ISOBUTYLPARABEN
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70350-2612-1 227 g in 1 JAR None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 09/01/2017
Labeler — SOLUTECH PHARMACEUTICALS LLC (080040396)

Revised: 03/2018 SOLUTECH PHARMACEUTICALS LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.